Elodie Sollier
Overview
Explore the profile of Elodie Sollier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu H, Vuppalapaty M, Hoerner C, Bergstrom C, Chiu M, Lemaire C, et al.
BMC Cancer
. 2024 Apr;
24(1):482.
PMID: 38627648
Background: Therapies for metastatic castration-resistant prostate cancer (mCRPC) include targeting the androgen receptor (AR) with androgen receptor inhibitors (ARIs) and prostate-specific membrane antigen (PSMA). Having the ability to detect AR,...
2.
Ongaro A, Ndlovu Z, Sollier E, Otieno C, Ondoa P, Street A, et al.
Lab Chip
. 2022 Jul;
22(17):3122-3137.
PMID: 35899603
Single-use, disposable, point-of-care diagnostic devices carry great promise for global health, including meeting urgent needs for testing and diagnosis in places with limited laboratory facilities. Unfortunately, the production and disposal...
3.
Liu H, Vuppalapaty M, Wilkerson C, Renier C, Chiu M, Lemaire C, et al.
Front Oncol
. 2020 Oct;
10:572895.
PMID: 33117705
Lung cancer is the leading cause of cancer-related mortality worldwide. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapies, based on the evaluation of mutations, have shown dramatic clinical...
4.
Razmara A, Sollier E, Kisirkoi G, Baker S, Bellon M, McMillan A, et al.
Clin Exp Metastasis
. 2020 Apr;
37(3):413-424.
PMID: 32335861
Patient-derived orthotopic xenograft (PDOX) models have been verified as a useful method for studying human cancers in mice. Previous studies on the extent of metastases in these models have been...
5.
Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al.
Breast Cancer Res
. 2019 Aug;
21(1):98.
PMID: 31462307
Background: Circulating tumor cells (CTCs) represent a temporal "snapshot" of a patient's cancer and changes that occur during disease evolution. There is an extensive literature studying CTCs in breast cancer...
6.
Raillon C, Che J, Thill S, Duchamp M, Desbiolles B, Millet A, et al.
Cytometry A
. 2019 Aug;
95(10):1085-1095.
PMID: 31364817
The isolation, analysis, and enumeration of circulating tumor cells (CTCs) from cancer patient blood samples are a paradigm shift for cancer patient diagnosis, prognosis, and treatment monitoring. Most methods used...
7.
Che J, Yu V, Dhar M, Renier C, Matsumoto M, Heirich K, et al.
Oncotarget
. 2016 Feb;
7(11):12748-60.
PMID: 26863573
Circulating tumor cells (CTCs) are emerging as rare but clinically significant non-invasive cellular biomarkers for cancer patient prognosis, treatment selection, and treatment monitoring. Current CTC isolation approaches, such as immunoaffinity,...
8.
Dhar M, Wong J, Karimi A, Che J, Renier C, Matsumoto M, et al.
Biomicrofluidics
. 2015 Dec;
9(6):064116.
PMID: 26697126
Circulating tumor cells (CTCs) are important biomarkers for monitoring tumor dynamics and efficacy of cancer therapy. Several technologies have been demonstrated to isolate CTCs with high efficiency but achieve a...
9.
Sollier E, Go D, Che J, Gossett D, OByrne S, Weaver W, et al.
Lab Chip
. 2013 Sep;
14(1):63-77.
PMID: 24061411
A blood-based, low cost alternative to radiation intensive CT and PET imaging is critically needed for cancer prognosis and management of its treatment. "Liquid biopsies" of circulating tumor cells (CTCs)...
10.
Kersaudy-Kerhoas M, Sollier E
Lab Chip
. 2013 Jul;
13(17):3323-46.
PMID: 23824514
Plasma is a rich mine of various biomarkers including proteins, metabolites and circulating nucleic acids. The diagnostic and therapeutic potential of these analytes has been quite recently uncovered, and the...